News - Patents


Current filters:


Popular Filters

426 to 434 of 434 results

Australia clears way for increased access to generic medicines


Australian consumers and health professionals will have more ready access to generic medicines following…


US FTC warns Sanofi, Watson and Synthon over Ambien patent deal, but won’t take action


The Federal Trade Commission’s Bureau of Competition has notified Sanofi-Aventis US, a subsidiary…

AmbienGenericsLegalNorth AmericaPatentsPharmaceuticalSanofi-AventisSynthonWatson Pharmaceuticals

Australian generic drugmakers welcome IP law to encourage R&D investment


Members of Australia’s Generic Medicines Industry Association (GMiA) have strongly welcomed the…


Chile remains on USTR Priority Watch list


The Office of the United States Trade Representative (USTR) released its annual Special 301 Report on…

GenericsLegalNorth AmericaPatentsPharmaceuticalSouth America

Generic drug sales in Brazil leapt 53% in 2010; double-digit growth forecast the next two years


In Brazil, sales last year of generic drugs - which are nearly identical reproductions of off-patent…

GenericsMarkets & MarketingPatentsSouth America

AstraZeneca and Pozen sue Dr Reddy’s over Vimovo patent


Anglo-Swedish drug major AstraZeneca (LSE: AZN and USA-based Pozen (Nasdaq; POZN) have filed a law suit…

Anti-Arthritics/RheumaticsAstraZenecaDr Reddy's LaboratoriesGenericsLegalNorth AmericaPatentsPharmaceuticalPozenVimovo

Mexico and the second medical use claims in the new European format for patents


Therapeutic treatment methods for humans or animals are excluded from patentability under most legal…

EuropePatentsPharmaceuticalSouth America

426 to 434 of 434 results

Back to top